Membranous nephropathy in a patient with ankylosing spondylitis

Rationale: Renal complications in ankylosing spondylitis (AS) were rarely observed, and proteinuria associated with AS can be seen often due to amyloidosis in this kind of complications, while membranous nephropathy (MN) is seldom considered. This article reports a case of coexistence of AS and MN, to provide the exact relationship of these 2 entities and recognized some causes of renal involvement in AS. Patient concerns: A 44-year-old female presented with pain of the left leg for 4 years and pedal edema for 2 weeks. Diagnoses: AS was diagnosed according to the patient's clinical manifestation and sacroiliitis observed on computed tomography (CT) scan. Nephrotic syndrome was found and MN was diagnosed according to kidney biopsy in which thickened capillary loops were observed with light microscopy, granular deposits of IgG along the capillary wall were observed using immunofluorescence staining, and subepithelial electron-dense deposits were observed with electron microscopy. No other secondary causes of MN were found on extensive investigations. Intervention: Given the diagnoses, the patient received nonimmunosuppressive therapy for MN and adalimumab for AS. Outcomes: The patient got pain relief, as well as urinary protein reduction. Lessons: This case suggested a secondary MN in association with AS and the relationship between these 2 diseases needed more concern and further illumination.

[1]  D. Amarapurkar,et al.  Spectrum of hepatitis B and renal involvement , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[2]  A. Levy,et al.  Estimating the Occurrence of Renal Complications Among Persons With Ankylosing Spondylitis , 2014, Arthritis care & research.

[3]  M. Troxell,et al.  Membranous nephropathy and nonsteroidal anti-inflammatory agents. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Eun Jung Lee,et al.  Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker , 2013, Rheumatology International.

[5]  Zhiming Lin,et al.  Adalimumab significantly reduces inflammation and serum DKK‐1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis , 2012, International journal of rheumatic diseases.

[6]  C. B. Taarit,et al.  Atteinte rénale au cours de la spondylarthrite ankylosante , 2012 .

[7]  R. Ram,et al.  Membranous nephropathy and granulomatous interstitial nephritis due to tuberculosis. , 2011, Clinical nephrology.

[8]  A. Banerjee,et al.  Membranous glomerulonephritis and tuberculous peritonitis: a rare association. , 2011, Journal of infection in developing countries.

[9]  D. Poddubnyy,et al.  Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis , 2011, Expert opinion on drug safety.

[10]  A. Cybulsky Membranous nephropathy. , 2011, Contributions to nephrology.

[11]  Lining Wang,et al.  Lumbar Tuberculosis Associated with Membranous Nephropathy and Interstitial Nephritis , 2010, Journal of Clinical Microbiology.

[12]  T. Nadasdy,et al.  An uncommon cause of membranous glomerulonephritis. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  A. Dinda,et al.  Membranous glomerulonephritis in a patient with ankylosing spondylitis: a rare association , 2009, Clinical and Experimental Nephrology.

[14]  K. Siamopoulos,et al.  Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  Paul Wordsworth,et al.  Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). , 2008, The Journal of rheumatology.

[16]  P. Rahman,et al.  Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. , 2007, Arthritis and rheumatism.

[17]  D. Memmos,et al.  Membranous glomerulonephritis complicating ankylosing spondylitis. , 2006, Clinical nephrology.

[18]  E. Fritschka,et al.  Renal diseases in ankylosing spondylitis: Review of the literature illustrated by case reports , 2005, Clinical Rheumatology.

[19]  V. D’Agati,et al.  Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. , 2003, Clinical nephrology.

[20]  T. Larson,et al.  Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. , 1997, JAMA.

[21]  T. Larson,et al.  Reversible Membranous Nephropathy Associated With the Use of Nonsteroidal Anti-inflammatory Drugs , 1996 .

[22]  D. Isenberg,et al.  Renal abnormalities in ankylosing spondylitis. , 1987, British journal of rheumatology.

[23]  M. García de la Torre,et al.  Membranous nephropathy in a patient with ankylosing spondylitis and rheumatoid arthritis. , 1985, Nephron.

[24]  Irby Wr,et al.  Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy. , 1981 .

[25]  W. R. Irby,et al.  Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy. , 1981, The Journal of rheumatology.

[26]  L. Revert,et al.  Membranous nephropathy in ankylosing spondylitis. , 1981, Nephron.